SCHEMBL5159523

SCHEMBL5159523

CC[C@@H](CNC(=O)c1ccccc1OC)c1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA3 P22001 1/20 0.68
HPGD P15428 3/20 0.60
ALDH1A1 P00352 2/20 0.60
TP53 P04637 1/20 0.58
GLA P06280 1/20 0.58
MAPK1 P28482 1/20 0.55
GAA P10253 1/20 0.54
MAPT P10636 1/20 0.54
CTSD P07339 1/20 0.54
HCN1 O60741 1/20 0.51
HCN4 Q9Y3Q4 1/20 0.51
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
POLB P06746 1/20 0.50
P2RX7 Q99572 1/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
KCNK3 O14649 2/20 0.49
KCNK9 Q9NPC2 2/20 0.49
LMNA P02545 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5159459 1.00 KCNA3 (0.68) KCNA3HPGDALDH1A1TP53GLA
SCHEMBL7976348 0.90 KCNA3 (0.65) KCNA3HPGDALDH1A1TP53GLA
SCHEMBL5162069 0.90 KCNA3 (0.65) KCNA3HPGDALDH1A1TP53GLA
SCHEMBL4965050 0.87 KCNA3 (0.69) KCNA3HPGDALDH1A1TP53GLA
SCHEMBL5157294 0.86 KCNA3 (0.75) KCNA3HPGDALDH1A1TP53GLA
SCHEMBL5161979 0.85 KCNA3 (0.62) KCNA3HPGDALDH1A1TP53GLA
SCHEMBL5161043 0.85 KCNA3 (0.62) KCNA3HPGDALDH1A1TP53GLA
SCHEMBL4960269 0.85 KCNA3 (0.62) KCNA3HPGDALDH1A1TP53GLA
SCHEMBL5160776 0.85 KCNA3 (0.62) KCNA3HPGDALDH1A1TP53GLA
SCHEMBL5158992 0.83 KCNA3 (0.76) KCNA3HPGDALDH1A1TP53GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1126836-B1 BENZAMIDE POTASSIUM CHANNEL INHIBITORS MERCK & CO INC (US) 2007-02-14 EP disclosed
US-6194458-B1 1-(2-METHOXYPHENYL)-1-OXO-2-AZA-(S)-4-I-BUTYL-4-PHENYLBUTANE, FOR EXAMPLE; TREATING VARIOUS CONDITIONS INCLUDING TRANSPLANTATION REJECTION OF ORGANS OR TISSUES IN A PATIENT; IMMUNOSUPPRESSANT COMPOSITIONS MERCK & CO., INC. 2001-02-27 US disclosed